Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Regenerative Medical Technology (RMTG) Total Debt (2017 - 2025)

Historic Total Debt for Regenerative Medical Technology (RMTG) over the last 9 years, with Q3 2025 value amounting to $17.0 million.

  • Regenerative Medical Technology's Total Debt rose 21721871.79% to $17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.0 million, marking a year-over-year increase of 21721871.79%. This contributed to the annual value of $2.0 million for FY2024, which is 2005572.09% up from last year.
  • Latest data reveals that Regenerative Medical Technology reported Total Debt of $17.0 million as of Q3 2025, which was up 21721871.79% from $2.8 million recorded in Q2 2025.
  • Over the past 5 years, Regenerative Medical Technology's Total Debt peaked at $17.0 million during Q3 2025, and registered a low of $7800.0 during Q1 2022.
  • In the last 5 years, Regenerative Medical Technology's Total Debt had a median value of $922053.0 in 2021 and averaged $3.9 million.
  • As far as peak fluctuations go, Regenerative Medical Technology's Total Debt tumbled by 9994.05% in 2023, and later soared by 21721871.79% in 2025.
  • Quarter analysis of 5 years shows Regenerative Medical Technology's Total Debt stood at $11.8 million in 2021, then crashed by 99.93% to $7800.0 in 2022, then increased by 27.51% to $9946.0 in 2023, then skyrocketed by 20055.72% to $2.0 million in 2024, then soared by 745.56% to $17.0 million in 2025.
  • Its last three reported values are $17.0 million in Q3 2025, $2.8 million for Q2 2025, and $2.0 million during Q1 2025.